Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New antibacterials discovered at Merck & Co.

Oct. 11, 2021

Enanta Pharmaceuticals synthesizes new anti-HBV compounds

Oct. 11, 2021

A global structural and competitive landscape of key antibody binding sites on SARS-CoV-2 spike

Oct. 6, 2021

Discovery of novel thiazolidinedione derivatives that inhibit HBV internalization

Oct. 6, 2021

SARS-CoV-2 virus-specific T-cell therapy may be effective against variants

Oct. 6, 2021

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Oct. 5, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

Oct. 5, 2021

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Oct. 1, 2021

New antivirals presented by EcoSynth, Transmare Chemie

Oct. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...